{"id":"W1757837840","doi":"10.1016/j.clinthera.2015.09.008","title":"Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014","year":2015,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Bayer (Canada); McGill University Health Centre; Regina Qu'Appelle Health Region; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Daiichi Sankyo Europe; Bayer Canada; Health Canada; Daiichi-Sankyo; Centro para el Desarrollo Tecnológico Industrial","keywords":"Medicine; Apixaban; Rivaroxaban; Medical prescription; Dabigatran; Warfarin; Vitamin K antagonist; Specialty; Reimbursement; Emergency medicine; Family medicine; Internal medicine; Atrial fibrillation; Pharmacology; Health care","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007123268,0.0003829349,0.0005059277,0.004058603,0.001845421,0.001661941,0.001539099,0.0006488715,0.002710232],"category_scores_gemma":[0.00540968,0.0003580623,0.0009098337,0.01116419,0.0006859583,0.0006837043,0.0007913227,0.001095796,0.0004042175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07085848,"about_ca_system_score_gemma":0.07708476,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9959022,"about_ca_topic_score_gemma":0.9967662,"domain_scores_codex":[0.9972053,0.00008175124,0.0003170674,0.0003568188,0.00153377,0.0005053558],"domain_scores_gemma":[0.9902447,0.0002204173,0.001932566,0.00009549627,0.006296926,0.001209855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001909139,0.00006731782,0.9584872,0.0004730309,0.0002231145,0.0001338678,0.0005471483,0.0006942654,0.000303303,0.0004319632,0.01962024,0.01882763],"study_design_scores_gemma":[0.00001608699,0.00003116825,0.9868677,0.0001337718,0.00007356044,0.0001546527,0.0005440663,0.0006593189,0.0001668949,0.00003051106,0.01130123,0.00002103173],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7789358,0.01564625,0.0006334716,0.008037288,0.0002075178,0.0001746702,0.1788907,0.0002542149,0.01722012],"genre_scores_gemma":[0.9415182,0.008976894,0.001448152,0.00199174,0.000111488,0.00008746226,0.04099531,0.0000432646,0.004827465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07085848,"threshold_uncertainty_score":0.5141166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4284872103572043,"score_gpt":0.4656241182411223,"score_spread":0.03713690788391794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}